|
Showing 1 - 2 of
2 matches in All Departments
Today, more than 70 years after Eugen Bleuler introduced the term
schizophrenia, the human condition so labeled continues to pose a
formidable challenge to the helping professions. In recent years it
may seem that this challenge can be met most successful- ly by
biologicalIy oriented researchers and therapists: AlI over the
world neuroleptic drugs have made it possible to control disturbing
symptoms and shorten hospital stays. Ever more refined technologies
permit study of intricate neurophysiological and pharma- cological
processes that seem to underlie, if not contribute to,
schizophrenic disorders. Most recently, the discovery of the
endorphins promises a new therapeutic breakthrough. At the same
time, a vast and growing research litera ture confirms the
importance, if not primacy, of hereditary and neurophysiological
fac tors in the etiopathogenesis of these disorders. And yet, as
Loren Mosher notes in this volume, after 2 decades of almost
universal usage of neuroleptics, it is now dear that they do not
cure schizophrenia. It is also c1ear that they have serious,
sometimes irreversible toxicities, that recovery may be impaired by
them in at least some schizophrenics, and that they have little
effect on long-term psychosocial adjustment.
Bei den h{ufigsten Krebserkrankungen werden der Einflu~ des Leidens
auf den Patienten und die Familie dargestellt, ebenso wie Einfl}sse
der psychosozialen Situation auf den Krankheitsverlauf. In einem
Vergleich verschiedener psycho- logischer Ma~nahmen werden m|gliche
positive und negative Wirkungen dargestellt. Ein Vergleich
verschiedener Nach- sorgesettings und eine
15-Jahres-Nachuntersuchung beim Colorektalkarzinom zeigt die
zwichenzeitlichen Ver{nderungen der psychosozialen Rehabilitation.
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.